Recently, Patrick added a company to his Transformational Technology Alert portfolio, which we believe has the most compelling drug candidate currently in development for the treatment of Alzheimer’s disease.
This drug, for the first time, has shown in early testing the ability to not only treat the symptoms of Alzheimer’s but also the advance of the disease itself. If this disease-modifying candidate progresses through trials and begins to reach those who need it, it would be a revolution in Alzheimer’s care, would slow runaway healthcare expenditures, and would be a boon to societal stability.
Any comments as to which company this might be.
This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.